Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Journal of Medical Virology

Volumn 78, Issue 3, 2006, Pages 400-407

  Kawada, Jun Ichi ^a   Kimura, Hiroshi ^a   Sbibata, Yukiko ^a   Hara, Shinya ^a   Hoshino, Yo ^a   Kojima, Seiji ^a   Nishikawa, Kazuo ^b   Morishima, Tsimeo ^c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagoya Ekisaikai Hospital   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cytochrome c; Epstein Barr virus; Hemophagocytic lymphohistiocytosis; Real time PCR

Indexed keywords

CYTOCHROME C; FAS LIGAND; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DISEASE MARKER; EPSTEIN BARR VIRUS; EVALUATION; FEMALE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; INFECTIOUS MONONUCLEOSIS; MALE; NONHUMAN; PATHOPHYSIOLOGY; STATISTICAL SIGNIFICANCE; VIRUS LOAD; VIRUS PATHOGENESIS;

APOPTOSIS; CHILD, PRESCHOOL; CYTOCHROMES C; EPSTEIN-BARR VIRUS INFECTIONS; FAS LIGAND PROTEIN; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; STATISTICS; TUMOR NECROSIS FACTORS; VIRAL LOAD;

HUMAN HERPESVIRUS 4;

EID: 33644654885     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20553     Document Type: Article

References (43)

1. Abello PA, Buchman TG. 1994. Heat shock-induced cell death in murine microvascular endothelial cells depends on priming with tumor necrosis factor-alpha or interferon-gamma. Shock 2:320-323.
2. Adachi N, Hirota M, Hamaguchi M, Okamoto K, Watanabe K, Endo F. 2004. Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome. Clin Chim Acta 342:127-136.
3. Akashi K, Hayashi S, Gondo H, Mizuno S, Harada M, Tamura K, Yamasaki K, Shibuya T, Uike N, Okamura T, et al. 1994. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol 87:243-250.
4. Arico M, Haupt R, Russotto VS, Bossi G, Scappaticci S, Danesino C. 2001. Langerhans cell histiocytosis in two generations: A new family and review of the literature. Med Pediatr Oncol 36:314-316.
5. Baker SJ, Reddy EP. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9.
6. Ben-Ari Z, Schmilovotz-Weiss H, Belinki A, Pappo O, Sulkes J, Neuman MG, Kaganovsky E, Kfir B, Tur-Kaspa R, Klein T. 2003. Circulating soluble cytochrome c in liver disease as a marker of apoptosis. J Intern Med 254:168-175.
7. Boehme MW, Galle P, Stremmel W. 2002. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 107:340-349.
8. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ. 1998. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 18:6353-6364.
9. Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB. 1998. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med 187:1395-1402.
10. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. 1989. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975-978.
11. Eichhorst ST, Krueger A, Muerkoster S, Fas SC, Golks A, Gruetzner U, Schubert L, Opelz C, Bilzer M, Gerbes AL, Krammer PH. 2004. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat Med 10:602-609.
12. Hasegawa D, Kojima S, Tatsumi E, Hayakawa A, Kosaka Y, Nakamura H, Sako M, Osugi Y, Nagata S, Sano K. 1998. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 91:2793-2799.
13. Renter JI, Arico M, Egeler RM, Blinder G, Favara BE, Filipovich AH, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S, Webb D. 1997. HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28:342-347.
14. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G. 2002. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100:2367-2373.
15. Hoshino Y, Morishima T, Kimura H, Nishikawa K, Tsurumi T, Kuzushima K. 1999. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection. J Immunol 163: 5735-5740.
16. Imashuku S. 2002. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44:259-272.
17. Imashuku S, Hibi S, Fujiwara F, Ikushima S, Todo S. 1994. Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Br J Haematol 88:656-658.
18. Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H, Chen J, Tsunematsu Y. 1995. Soluble interleukin-2 receptor: A useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 86:4706-4707.
19. Imashuku S, Hibi S, Ohara T, Iwai A, Sako M, Kato M, Arakawa H, Sotomatsu M, Kataoka S, Asami K, Hasegawa D, Kosaka Y, Sano K, Igarashi N, Maruhashi K, Ichimi R, Kawasaki H, Maeda N, Tanizawa A, Arai K, Abe T, Hisakawa H, Miyashita H, Henter JI. 1999. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 93:1869-1874.
20. Ishii E, Ohga S, Aoki T, Yamada S, Sako M, Tasaka H, Kuwano A, Sasaki M, Tsunematsu Y, Ueda K. 1991. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: Correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol 85:93-99.
21. Kawada J, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T, Morishima T. 2003. Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis 188:690-698.
22. Kawada J, Kimura H, Ito Y, Ando Y, Tanaka-Kitajima N, Hayakawa M, Nunoi H, Endo F, Morishima T. 2004. Evaluation of systemic inflammatory responses in neonates with herpes simplex virus infection. J Infect Dis 190:494-498.
23. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N, et al. 1993. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 92:1444-1450.
24. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. 1999. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37:132-136.
25. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. 2001. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98:280-286.
26. Kimura H, Hoshino Y, Kara S, Nishikawa K, Sako M, Hirayama M, Komada Y, Morishima T. 2002. Viral load in Epstein-Barr virus-associated hemophagocytic syndrome. Microbiol Immunol 46:579-582.
27. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. 1997. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
28. Kuzushima K, Kimura H, Hoshino Y, Yoshimi A, Tsuge I, Horibe K, Morishima T, Tsurumi T, Kojima S. 2000. Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder. J Infect Dis 182:937-940.
29. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. 1997. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 100: 1969-1979.
30. Luetjens CM, Kogel D, Reimertz C, Dussmann H, Renz A, Schulze-Osthoff K, Nieminen AL, Poppe M, Prehn JH. 2001. Multiple kinetics of mitochondrial cytochrome c release in drug-induced apoptosis. Mol Pharmacol 60:1008-1019.
31. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-365.
32. Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, Kai T, Suda M, Ueda K. 1993. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol 15:291-298.
33. Ohshima K, Shimazaki K, Sugihara M, Haraoka S, Suzumiya J, Kanda M, Kawasaki C, Kikuchi M. 1999. Clinicopathological findings of virus-associated hemophagocytic syndrome in bone marrow: Association with Epstein-Barr virus and apoptosis. Pathol Int 49:533-540.
34. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, Ohta H, Fujisaki H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S, Tawa A. 1997. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89:4100-4103.
35. Papathanassoglou ED, Moynihan JA, Ackerman MH. 2000. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework. Crit Care Med 28:537-549.
36. Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M. 2001. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 98:1542-1548.
37. Rickinson AB, Kieff E. 2001. Epstein-Barr Virus. In: Knipe DM, Howley PM, editors. Fields virology, 4 edn Philadelphia: Lippincott, Williams, and Wilkins. pp 2575-2627.
38. Rogy MA, Coyle SM, Oldenburg HS, Rock CS, Barie PS, Van Zee KJ, Smith CG, Moldawer LL, Lowry SF. 1994. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 178:132-138.
39. Suda T, Takahashi T, Golstein P, Nagata S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
40. Sumaya CV, Ench Y. 1985. Epstein-Barr virus infectious mononucleosis in children I. Clinical and general laboratory findings. Pediatrics 75:1003-1010.
41. Tanaka M, Suda T, Takahashi T, Nagata S. 1995. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 14:1129-1135.
42. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S. 1996. Fas ligand in human serum. Nat Med 2:317-322.
43. Thijs LG, Hack CE. 1995. Time course of cytokine levels in sepsis. Intensive Care Med 21:8258-263.